Gene expression profiling data can be used in toxicology to assess both the level and impact of toxicant exposure, aligned with a vision of 21st century toxicology. Here, we present a whole blood-derived gene signature that can distinguish current smokers from either nonsmokers or former smokers with high specificity and sensitivity. Such a signature that can be measured in a surrogate tissue (whole blood) may help in monitoring smoking exposure as well as discontinuation of exposure when the primarily impacted tissue (e.g., lung) is not readily accessible. The signature consisted of LRRN3, SASH1, PALLD, RGL1, TNFRSF17, CDKN1C, IGJ, RRM2, ID3, SERPING1, and FUCA1. Several members of this signature have been previously described in the context of smoking. The signature translated well across species and could distinguish mice that were exposed to cigarette smoke from ones exposed to air only or had been withdrawn from cigarette smoke exposure. Finally, the small signature of only 11 genes could be converted into a polymerase chain reaction-based assay that could serve as a marker to monitor compliance with a smoking abstinence protocol.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1177/0960327115600364 | DOI Listing |
Aust N Z J Public Health
January 2025
General Practice Clinical Unit, Faculty of Medicine, The University of Queensland, Brisbane, Australia; Te Kaupeka Oranga | Faculty of Health, Te Whare Wānanga o Waitaha | University of Canterbury, Ōtautahi | Christchurch, New Zealand.
Objective: This study aimed to measure associations between protective factors associated with positive psychological outcomes for Aboriginal and Torres Strait Islander youth living in an urban area.
Methods: Our primary outcome was the absence of psychological distress, reflecting a positive-outcome approach to analyse health assessment data, using modified Poisson regression, from a cohort of Aboriginal and Torres Strait Islander youth aged 15 to 24 years attending an urban Aboriginal and Torres Strait Islander health service (2016-2021).
Results: Health assessments from 710 participants were analysed, with 72.
J Med Internet Res
January 2025
Department of Engineering Management and Systems Engineering, George Washington University, Washington, DC, United States.
Background: Large language model (LLM) artificial intelligence chatbots using generative language can offer smoking cessation information and advice. However, little is known about the reliability of the information provided to users.
Objective: This study aims to examine whether 3 ChatGPT chatbots-the World Health Organization's Sarah, BeFreeGPT, and BasicGPT-provide reliable information on how to quit smoking.
PLoS One
January 2025
Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
Introduction: A long-term engagement (LTE) intervention was embedded in a social marketing campaign aimed at motivating quit attempts among Canadian adult commercial tobacco users 35 to 64 years of age. The purpose of this study was to examine the effectiveness and appeal of LTE within a marketing campaign.
Methods: 3,199 Canadians who smoked cigarettes aged 35-64 recruited using Facebook and Instagram advertisements were randomized into Intervention and Control groups.
Nicotine Tob Res
January 2025
Masonic Cancer Center, University of Minnesota, 420 Delaware Street SE, Minneapolis, MN.
Introduction: Hormonal contraceptives (HCs), which contain synthetic forms of estrogen (i.e., ethinyl estradiol) and/or progesterone (i.
View Article and Find Full Text PDFBiomarkers
January 2025
PMI R&D, Philip Morris Products S.A., Neuchâtel, Switzerland.
Background: Growing evidence indicates that noncombustible products could be a tobacco harm reduction tool for smokers who do not quit. The Tobacco Heating System (THS) emits substantially lower levels of harmful cigarette smoke constituents, and previous randomized clinical studies showed improved levels of biomarkers of potential harm (BoPH) linked to smoking-related disease.
Methods: In this cross-sectional study of healthy participants (n = 982) who (i) smoked cigarettes, (ii) had voluntarily switched from smoking to THS use, or (iii) formerly smoked, blood and urine samples were assayed for nine BoPH.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!